2.2. Effect of CTL1 and CTL2 Expression Levels on Survival of Pancreatic Adenocarcinoma (PAAD) Patients Using a Bioinformatics Analysis. This evidence concerns the gene SLC44A2 and pancreatic adenocarcinoma.